Literature DB >> 15328352

A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.

Hiroyuki Takahashi1, Shosaku Hattori, Akihiro Iwamatsu, Hajime Takizawa, Masabumi Shibuya.   

Abstract

Vascular endothelial growth factor (VEGF)/vascular permeability factor induces both angiogenesis and vascular permeability mainly through VEGF receptor (VEGFR)-2 activation. VEGF binds VEGFR-1 as well, but the importance of VEGFR-1 signaling in vascular permeability has been largely neglected. Here, we report the purification and characterization of a novel VEGF-like protein from Trimeresurus flavoviridis Habu snake venom. The Habu snake has a venom-specific VEGF-like molecule, T. flavoviridis snake venom VEGF (TfsvVEGF), in addition to VEGF-A. TfsvVEGF has almost 10-fold less mitotic activity than VEGF(165), a predominant isoform of human VEGF-A, but a similar effect on vascular permeability. TfsvVEGF bound VEGFR-1 and induced its autophosphorylation to almost the same extent as VEGF(165), but bound VEGFR-2 weakly and induced its autophosphorylation almost 10-fold less effectively than VEGF(165). This unique binding affinity for VEGFR-1 and VEGFR-2 leads to the vascular permeability-dominant activity of TfsvVEGF. These results suggest that Habu snakes have acquired a highly purposive molecule for a toxin, which enhances the toxicity in envenomation without inducing effective angiogenesis and the following regeneration of damaged tissues, taking advantage of the difference in signaling properties involving VEGFR-1 and VEGFR-2 between vascular permeability and angiogenesis. TfsvVEGF is thus a potent inducing factor selective for vascular permeability through preferential signaling via VEGFR-1. These data strongly indicate the importance of VEGFR-1 signaling in vascular permeability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328352     DOI: 10.1074/jbc.M403687200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.

Authors:  Puneet Kumar; Qiang Shen; Christopher D Pivetti; Eugene S Lee; Mack H Wu; Sarah Y Yuan
Journal:  Expert Rev Mol Med       Date:  2009-06-30       Impact factor: 5.600

2.  Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.

Authors:  N Miyamoto; Y de Kozak; J C Jeanny; A Glotin; F Mascarelli; P Massin; D BenEzra; F Behar-Cohen
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

3.  Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer.

Authors:  Masabumi Shibuya
Journal:  Genes Cancer       Date:  2010-11

4.  Schizophrenia-derived hiPSC brain microvascular endothelial-like cells show impairments in angiogenesis and blood-brain barrier function.

Authors:  Bárbara S Casas; Gabriela Vitória; Catalina P Prieto; Mariana Casas; Carlos Chacón; Markus Uhrig; Fernando Ezquer; Marcelo Ezquer; Stevens K Rehen; Verónica Palma
Journal:  Mol Psychiatry       Date:  2022-06-15       Impact factor: 15.992

5.  What's new in emergencies, trauma, and shock? Snake envenomation and organophosphate poisoning in the emergency department.

Authors:  Praveen Aggarwal; Nayer Jamshed
Journal:  J Emerg Trauma Shock       Date:  2008-07

6.  Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia.

Authors:  Richa Tripathi; Gayatri Rath; Ranju Ralhan; Sunita Saxena; Sudha Salhan
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

7.  Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.

Authors:  Yasuo Yamazaki; Yukiko Matsunaga; Yuko Tokunaga; Shinya Obayashi; Mai Saito; Takashi Morita
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

8.  Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.

Authors:  Masabumi Shibuya
Journal:  Genes Cancer       Date:  2011-12

Review 9.  Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Curr Drug Targets       Date:  2010-08       Impact factor: 3.465

10.  Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders.

Authors:  Mansour Homayouni
Journal:  J Ophthalmic Vis Res       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.